G-Protein-coupled receptors in HL-60 human leukemia cells

General Pharmacology

Volumn 27, Issue 1, 1996, Pages 33-54

  Klinker, Jan F ^a   Wenzel Seifert, Katharina ^a,b   Seifert, Roland ^a,b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Differentiation; Effector systems; G protein activation; G proteins; Heptahelical receptors; HL 60 cells; Receptor independent

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; BETA 2 ADRENERGIC RECEPTOR; BUCLADESINE; CALCITRIOL; CATION CHANNEL; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; FORMYLPEPTIDE; FORMYLPEPTIDE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTAMINE; HISTAMINE DERIVATIVE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROSTAGLANDIN RECEPTOR; PURINE NUCLEOTIDE; PURINE RECEPTOR; PYRIMIDINE NUCLEOTIDE; RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBOCYTE ACTIVATING FACTOR RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; URIDINE TRIPHOSPHATE;

CELL DIFFERENTIATION; CELL STRAIN HL 60; HUMAN; HUMAN CELL; LEUKEMIA CELL; MODEL; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROMYELOCYTE; REVIEW; SIGNAL TRANSDUCTION;

EID: 0029670250     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)00107-7     Document Type: Review

References (237)

1. Abramson S. B., Leszczynska-Piziak J. and Weissmann G. (1991) Arachidonic acid as a second messenger. Interactions with a GTP-binding protein of human neutrophils. J. Immunol. 147, 231-236.
2. Ali H., Richardson R. M., Tomhave E. D., Didsbury J. R. and Snyderman R. (1993) Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitization. J. Biol. Chem. 268, 24247-24254.
3. 2+ stores. Biochem. J. 289, 761-766.
4. Amatruda T. T. III, Steele D. A., Slepak V. Z. and Simon M. I. (1991) Ga16, a G protein α subunit specifically expressed in hematopoietic cells. Proc. natn. Acad. Sci. USA 88, 5587-5591.
5. Amatruda T. T. III, Gerard N. P., Gerard C. and Simon M. I. (1993) Specific interactions of chemoattractant factor receptors with G-proteins. J. Biol. Chem. 268, 10139-10144.
6. Baggiolini M. and Dewald B. (1984) Exocytosis by neutrophils. In Regulation of leukocyte function (Edited by Snyderman, R. E.), pp. 221-246, Plenum Press, New York.
7. Baggiolini M., Boulay F., Badwey F. and Curnutte J. T. (1993) Activation of neutrophil leukocytes: chemoattractant receptors and respiratory burst. FASEB J. 7, 1004-1010.
8. Birnbaumer L., Abramowitz J. and Brown A. M. (1990) Receptor-effector coupling by G-proteins. Biochim. Biophys. Acta 1031, 163-224.
9. 1 histamine receptor signaling in Balb/3T3 cells transformed by ν-K-ras and ν-H-ras oncogenes. Oncogene 7, 2053-2057.
10. Bokoch G. M. (1993) Biology of the rap proteins, members of the ras superfamily of GTP-binding proteins. Biochem. J. 289, 17-24.
11. Bommakanti R. K., Bokoch G. M., Tolley J. O., Schreiber R. E., Siemsen D. W., Klotz K.-N. and Jesaitis A. J. (1992) Reconstitution of a physical complex between the N-formyl chemotactic peptide receptor and G protein. Inhibition by pertussis toxin-catalyzed ADP ribosylation. J. Biol. Chem. 267, 7576-7581.
12. Bommakanti R. K., Klotz K.-N., Dratz E. A. and Jesaitis A. J. (1993) A carboxy-terminal tail peptide of neutrophil chemotactic receptor disrupts its physical complex with G protein. J. Leukocyte Biol. 54, 572-577.
13. Boulay F., Tardif F., Brouchon L. and Vignais P. (1990) The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 29, 11123-11133.
14. Boulay F., Mery L., Tardif M., Brouchon L. and Vignais P. (1991) Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry 30, 2993-2999.
15. Bourgoin S. and Grinstein S. (1992) Peroxides of vanadate induce activation of phospholipase D in HL-60 cells. Role of tyrosine phosphorylation. J. Biol. Chem. 267, 11908-11916.
16. Bourne H. R., Sanders D. A. and McCormick F. (1990) The GTPase superfamily: A conserved switch for diverse cell functions. Nature 348, 125-132.
17. Brandes L. J., LaBella F. S., Glavin G. B., Paraskevas F., Saxena S. P., McNicol A. and Gerrard J. M. (1990) Histamine as an intracellular messenger. Biochem. Pharmacol. 40, 1677-1681.
18. Brandt S. J., Dougherty R. W., Lapetina E. G. and Niedel J. E. (1985) Pertussis toxin inhibits chemotactic peptide-stimulated generation of inositol phosphates and lysosomal enzyme secretion in human leukemic (HL-60) cells. Proc. natn. Acad. Sci. USA 82, 3277-3280.
19. Breitman T. R., Selonick S. E. and Collins S. J. (1980) Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. natn. Acad. Sci. USA 77, 2936-2940.
20. Brown H. A., Gutowski S., Moomaw C. R., Slaughter C. and Sternweis P. C. (1993) ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity. Cell 75, 1137-1144.
21. 2+ influx in all-trans-differentiated HL-60 cells independently of phospholipase or adenylyl cyclase. Naunyn-Schmiedeberg's Arch. Pharmacol. (in press).
22. 2-receptors. Naunyn-Schmiedeberg's Arch. Pharmac. 340, 671-678.
23. 2-receptors involved in the regulation of NADPH oxidase? Naunyn-Schmiedeberg's Arch. Pharmac. 341, 455-461.
24. Buschauer A. (1989) Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs. J. Med. Chem. 32, 1963-1970.
25. Buschauer A., Schunack W., Arrang J.-M., Garbarg M., Schwartz J. C. and Young J. M. (1989) Histamine receptors. In Clinical Pharmacology Vol 13: Receptor Pharmacology and Function (Edited by Williams M., Glennon R. A. and Timmermans P. B. M. W. M.), pp. 293-348. Marcel Dekker, New York.
26. 1) receptor radioligand binding studies on normal T cell subsets, B cells, and monocytes. J. Immunol 136, 2116-2120.
27. 2 by G-protein -βγ-subunits. Nature 369, 684-686.
28. Carp H. (1982) Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J. Exp. Med. 155, 264-275.
29. Channock S. J., El Benna J., Smith R. M. and Babior B. M. (1994) The respiratory burst oxidase. J. Biol. Chem. 269, 24519-24522.
30. Chaplinski T. J. and Niedel J. E. (1982) Cyclic nucleotide-induced maturation of human promyelocytic leukemia cells. J. Clin. Invest. 70, 953-964.
31. Chuang T. T., Sallese M., Ambrosini G., Parruti G. and De Blasi A. (1992) High expression of β-adrenergic receptor kinase in human peripheral blood leukocytes. Isoproterenol and platelet activating factor can induce kinase translocation. J. Biol. Chem. 267, 6886-6892.
32. 2+. Biochem. J. 275, 127-131.
33. Cockcroft S. and Stutchfield J. (1989) ATP stimulates secretion in human neutrophils and HL60 cells via a pertussis toxin-sensitive guanine nucleotide-binding protein coupled to phospholipase C. FEBS Lett. 245, 25-29.
34. Cockcroft S., Thomas G. M. H., Fensome A., Geny B., Cunningham E., Gout I., Hiles I., Totty N. F., Truong O. and Hsuan J. J. (1994) Phospholipase D: a downstream effector of ARF in granulocytes. Science 263, 523-526.
35. Collins S. J. (1987) The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression. Blood 70, 1233-1244.
36. Collins S. J., Ruscetti F. W., Gallagher R. E. and Gallo R. C. (1978) Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. natn. Acad. Sci. USA 75, 2458-2462.
37. Connolly G. P., Harrison P. J. and Stone T. W. (1993) Action of purine and pyrimidine nucleotides on the rat superior cervical ganglion. Br. J. Pharmac. 110, 1297-1304.
38. Cowen D. S., Lazarus H. M., Shurin S. B., Stoll S. E. and Dubyak G. R. (1989) Extracellular adenosine triphosphate activates calcium mobilization in human phagocytic leukocytes and neutrophil/monocyte progenitor cells. J. Clin. Invest. 83, 1651-1660.
39. 2-purinergic, and chemotactic peptide-stimulated inositol phospholipid breakdown in HL-60 cells and HL-60 membranes. J. Biol. Chem. 265, 16181-16189.
40. 2-purinergic receptors activate a guanine nucleotide-dependent phospholipase C in membranes from HL-60 cells. Biochim. Biophys. Acta 1053, 195-203.
41. 2-purinergic receptor agonists induces phenotypic modulation of the HL-60 and U937 human myelogenous leukemia cell lines. J. Leukocyte Biol. 50, 109-122.
42. 2 generation, respectively. J. Clin. Invest. 85, 1150-1157.
43. Dahlgren C., Andersson T. and Stendahl O. (1987) Chemotactic factor binding and functional capacity: A comparison between human granulocytes and differentiated HL-60 cells. J. Leukocyte Biol. 42, 245-252.
44. 1 receptor. Biochem. Biophys. Res. Commun. 197, 1601-1608.
45. De Cremoux P., Zimber A., Calvo F., Lanotte M., Mercken L. and Abita J. P. (1991) Gsα availability to cholera toxin-catalyzed ADP-ribosylation is decreased in membranes of retinoic acid-treated leukemic cell lines HL-60 and THP-1. A posttranslational effect. Biochem. Pharmac. 42, 2141-2146.
46. i signaling systems. Am. J. Physiol. 263, G967-G972.
47. 2+ stores and activates an influx pathway for divalent cations in HL-60 cells. J. Biol. Chem. 267, 2318-2324.
48. 2+ stores. J. Clin. Invest. 90, 830-839.
49. Detert H., Hagelüken A., Seifert R., Schunack W. (1995) 2-Substituted histamines with G-protein-stimulatory activity. Eur. J. Med. Chem. 30, 271-276.
50. Didsbury J. R., Uhing R. J., Tomhave E., Gerard C., Gerard N. and Snyderman R. (1991) Receptor class desensitization of leukocyte chemoattractant receptors. Proc. natn. Acad. Sci. USA 88, 11564-11568.
51. Dillon S. B., Verghese M. W. and Snyderman R. (1988) Signal transduction in cells following binding of chemoattractants to membrane receptors. Virchows Archiv B Cell. Pathol. 55, 65-80.
52. Driver A. G., Kukoly C. A. and Bennett T. E. (1989) Expression of histamine HI receptors on cultured histiocytic lymphoma cells. Biochem. Pharmacol. 38, 3083-3091.
53. 2-purinergic receptors for extracellular ATP. Evidence for mediation by both pertussis toxin-sensitive and pertussis toxin-insensitive mechanisms. J. Biol. Chem. 263, 18108-18117.
54. Dunkel C. G., Saffitz J. E. and Evers A. S. (1989) fMet-Leu-Phe receptor expression by an interstitial cell in rabbit right atrium following left ventricular myocardial infarction. Circ. Res. 65, 215-223.
55. 2U purinergic receptor. Proc. natn. Acad. Sci. USA 90, 10449-10453.
56. Erbeck K., Klein J. B. and McLeish K. R. (1993) Differential uncoupling of chemoattractant receptors from G proteins in retinoic acid-differentiated HL-60 granulocytes. J. Immunol. 150, 1913-1921.
57. 2,2′-O-dibutyryl guanosine 3′: 5′-cyclic monophosphate. Naunyn-Schmiedeberg's Arch. Pharmac. 343, 370-376.
58. Exton J. H. (1994) Phosphatidylcholine breakdown and signal transduction. Biochim. Biophys. Acta 1212, 26-42.
59. 2-receptors. Agents Actions 9, 1-3.
60. 2+ influx: how many mechanisms for how many channels? Trends Pharmacol. Sci. 15, 77-83.
61. 2+. Proc. natn. Acad. Sci. USA 89, 509-513.
62. 4 receptors in HL-60 cells. Blood 81, 3395-3403.
63. Francis J. W., Todd R. F. III, Boxer L. A. and Petty H. R. (1991) Histamine inhibits cell spreading and C3bi receptor clustering and diminishes hydrogen peroxide production by adherent human neutrophils. J. Cell. Physiol. 147, 128-137.
64. 1 receptor gene. Biochem. Biophys. Res. Commun. 201, 894-901.
65. Gabig T. G., English D., Akard L. P. and Schell M. J. (1987) Regulation of neutrophil NADPH oxidase activation in a cell-free system by guanine nucleotides and fluoride. Evidence for participation of a pertussis and cholera toxin-insensitive G protein. J. Biol. Chem. 262, 1685-1690.
66. 2 receptor. Proc. natn. Acad. Sci. USA 88, 429-433.
67. 2 receptor. Biochem. Biophys. Res. Commun. 178, 1386-1392.
68. Gerard C. and Gerard N. P. (1994) C5a anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 12, 775-808.
69. Gespach C. and Abita J.-P. (1982) Human polymorphonuclear neutrophils. Pharmacological characterization of histamine receptors mediating the elevation of cyclic AMP. Mol. Pharmocol. 21, 78-85.
70. Gespach C., Saal F., Cost H. and Abita J.-P. (1982) Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils. Mol. Pharmocol. 22, 547-553.
71. 2 receptor activity during the differentiation of the human monocytic-like cell line U-937. Comparison with prostaglandins and isoproterenol. FEBS Lett. 184, 207-213.
72. 2-receptors in the human promyelocytic leukemia cell line HL-60. Agents Actions 16, 279-283.
73. i-proteins mediate formyl peptide receptor signal transduction in human leukemia (HL-60) cells. J. Biol. Chem. 264, 21470-21473.
74. + regulation of formyl peptide receptor-mediated signal transduction in HL 60 cells. Evidence that the cation prevents activation of the G-protein by unoccupied receptors. Eur. J. Pharmac. 172, 481-492.
75. 2+ control of formyl-peptide receptor-G-protein interaction in HL 60 cells. Evidence that the low-agonist-affinity receptor interacts with and activates the G-protein. Eur. J. Biochem. 183, 97-105.
76. Gierschik P., Moghtader R., Sträub C., Dietrich K. and Jakobs K. H. (1991) Signal amplification in HL-60 granulocytes. Evidence that the chemotactic peptide receptor catalytically activates guanine-nucleotide-binding regulatory proteins in native plasma membranes. Eur. J. Biochem. 197, 725-732.
77. Gilman A. G. (1987) G proteins: Transducers of receptor-generated signals. Annu. Rev. Biochem. 56, 615-649.
78. Goetzl E., Shames R. S., Yang J., Birke F. W., Fang Liu Y., Albert P. R. and An S. (1994) Inhibition of human HL-60 cell responses to chemotactic factors by antisense messenger RNA depletion of G proteins. J. Biol. Chem. 269, 809-812.
79. 2+ mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells. J. Biol. Chem. 267, 4479-4488.
80. Hadjokas N., Bayer C. and Nielson C. P. (1992) Impaired stimulus-response coupling in association with impaired growth rate of HL60 cells. J. Leukocyte Biol. 52, 157-160.
81. Hagelüken, A., Grünbaum, L., Nürnberg, B., Harhammer, R., Schunack, W. and Seifert R. (1994) Lipophilic β-adrenoceptor antagonists and local anesthetics are effective direct activators of G-proteins. Biochem. Pharmac. 47, 1789-1795.
82. Hagelüken A., Grünbaum L., Klinker J., Nürnberg B., Harhammer R., Schultz G., Leschke C., Schunack W. and Seifert R. (1995a) Histamine receptor-dependent and/or -independent activation of guanine nucleotide-binding proteins by histamine and 2-substituted histamine derivatives in human leukemia (HL-60)- and human erythroleukemia (HEL) cells. Biochem. Pharmac. 49, 901-914.
83. Hagelüken A., Burde R., Nürnberg B., Harhammer R., Buschauer A., Seifert, R. (1995b) Cationic-amphiphilic arpromidine-derived guanidines and a histamine trifluoromethyl-toluidide derivative may activate pertussis toxin-sensitive G-proteins by a receptor-independent mechanism. Naunyn-Schmiedeberg's Arch. Pharmac. 351, 305-308.
84. Hagelüken A., Nürnberg B., Harhammer R., Grünbaum L., Schunack W. and Seifert R. (1995c) The class III antiarrhythmic drug, amiodarone, directly activates pertussis toxin-sensitive G-proteins. Mol. Pharmac. 47, 234-240.
85. Harris P. E. and Ralph P. (1985) Human leukemic models of myelomonocytic development: A review of the HL-60 and U937 cell lines. J. Leukocyte Biol. 37, 407-422.
86. Higashijima T., Uzu S., Nakajima T. and Ross E. M. (1988) Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J. Biol. Chem. 263, 6491-6494.
87. Hill S. J. (1990) Distribution, properties, and functional characteristics of three classes of histamine receptors. Pharmac. Rev. 42, 45-83.
88. Hoessly M. C., Rossi R. M. and Fischkoff S. A. (1989) Factors responsible for variable reported lineages of HL-60 cells induced to mature with butyric acid. Cancer Res. 49, 3594-3597.
89. Hoover R. L. and Wright T. C. (1983) Chemotaxis of endothelial cells to formylmethionyl-leucyl-phenylalanine. Microvas. Res. 26, 122-125.
90. Horuk R. (1994) Molecular properties of the chemokine receptor family. Trends Pharmac. Sci. 15, 159-165.
91. Hoyer D. and Boddeke H. W. G. M. (1993) Partial agonists, full agonists, antagonists: dilemmas of definition. Trends Pharmac. Sci. 14, 270-275.
92. Iannone, M. A., Wolberg, G. and Zimmerman T. P. (1989) Chemotactic peptide induces cAMP elevation in human neutrophils by amplification of the adenylate cyclase response to endogenously produced adenosine. J. Biol. Chem. 264, 20177-20180.
93. Iiri T., Tonkin M., Morishima N., Ohoka Y., Ui M. and Katada T. (1989) Chemotactic peptide receptor-supported ADP-ribosylation of a pertussis toxin substrate GTP-binding protein by cholera toxin in neutrophil-type HL-60 cells. J. Biol. Chem. 264, 21394-21400.
94. Imamura K., Sherman M. L., Spriggs D. and Kufe D. (1988) Effect of tumor necrosis factor on GTP binding and GTPase activity in HL-60 and L929 cells. J. Biol. Chem. 263, 10247-10253.
95. 2+ influx in HL-60 granulocytes involves GTP-sensitive elements. J. Biol. Chem. 268, 26075-26078.
96. James S. R., Vaziri C., Walker T. R., Milligan G. and Downes C. P. (1994) The turkey erythrocyte β-adrenergic receptor couples to both adenylate cyclase and phospholipase C via distinct G-protein α subunits. Biochem. J. 304, 359-364.
97. 2+ and cell growth. Am. J. Physiol. 258, C533-C543.
98. Joyce R. A. (1992) Chemical agents which suppress myelopoiesis: Agranulocytosis and leukemia. In Biochemical pharmacology of blood and bloodforming organs (Edited by Fisher, J. W.), pp. 493-522. Springer, Berlin.
99. Jungblut P. R. and Seifert R. (1990) Analysis by high-resolution two-dimensional electrophoresis of differentiation-dependent alterations in cytosolic protein pattern of HL-60 leukemic cells. J. Biochem. Biophys. Meth. 21, 47-58.
100. Kahn R. A. (1991) Fluoride is not an activator of the smaller (20-25 kDa) GTP-binding proteins. J. Biol. Chem. 266, 15595-15597.
101. Kaldenberg-Stasch S., Baden M., Fesseler B., Jakobs K. H. and Wieland T. (1994) Receptor-stimulated guanine-nucleotide-triphosphate binding to guanine-nucleotide-binding regulatory proteins. Nucleotide exchange and β-subunit-mediated phosphotransfer reactions. Eur. J. Biochem. 221, 25-33.
102. Kanaho Y., Kermode J. C. and Becker E. L. (1990) Comparison of stimulation by chemotactic formyl peptide analogs between GTPase activity in neutrophil plasma membranes and granule enzyme release from intact neutrophils. J. Leukocyte Biol. 47, 420-428.
103. Khan M. M., Melmon K. L., Marr-Leisy D., Verlander M. S., Egli M., Lok S. and Goodman M. (1987) Congener derivatives and conjugates of histamine: Synthesis and tissue and receptor selectivity of the derivatives. J. Med. Chem. 30, 2115-2120.
104. o of the plasma membranes ADP-ribosylated by pertussis toxin. J. Biol. Chem. 261, 11558-11562.
105. i-proteins in HL-60 membranes indirectly through interaction with nucleoside diphosphate kinase. Biochem. J. 304, 377-383.
106. Klinker J. F., Schwaner I., Offermanns S., Hagelüken A. and Seifert R. (1994b) Differential activation of dibutyryl cAMP-differentiated HL-60 human leukemia cells by chemoattractants. Biochem. Pharmac. 48, 1857-1864.
107. Klotz K.-N. and Jesaitis A. J. (1994) Neutrophil chemoattractant receptors and the membrane skeleton. BioEssays 16, 1-6.
108. Krause K.-H., Schlegel W., Wollheim C. B., Andersson T., Waldvogel F. A. and Lew P. D. (1985) Chemotactic peptide activation of human neutrophils and HL-60 cells. Pertussis toxin reveals correlation between inositol trisphosphate generation, calcium transients, and cellular activation. J. Clin. Invest. 76, 1348-1354.
109. + in the activation of β-glucuronidase release and superoxide production. Biochem. J. 288, 1025-1035.
110. Krautwurst D., Hescheler J., Arndts D., Lösel W., Hammer R. and Schultz G. (1993) Novel potent inhibitor of receptor-activated nonselective cation currents in HL-60 cells. Mol. Pharmac. 43, 655-659.
111. Kupper R. W., Dewald B., Jakobs K. H., Baggiolini M. and Gierschik P. (1992) G-protein activation by interleukin 8 and related cytokines in human neutrophil plasma membranes. Biochem. J. 282, 429-434.
112. 1-proteins in membranes of HL-60 cells. Cell. Signal. 4, 425-433.
113. Lazarowski E. R. and Harden T. K. (1994) Identification of a uridine nucleotide-selective G-protein-linked receptor that activates phospholipase C. J. Biol. Chem. 269, 11830-11836.
114. Lederer E. D., Jacobs A. A. and McLeish K. R. (1993) Desensitization by protein kinase C activation differentially uncouples formyl peptide receptors from effector enzymes in HL-60 granulocytes. Cell. Signal. 5, 735-745.
115. LeDuc L. E., Brown L. and Vidrich A. (1994) Bradykinin and FMLP stimulate prostanoid production by adult colonocytes in culture. Am. J. Physiol. 267, G778-G785.
116. Leglise M. C., Dent G. A., Ayscue L. H. and Ross D. W. (1988) Leukemic cell maturation. Phenotypic variability and oncogene expression in HL60 cells: A review. Blood Cells 13, 319-337.
117. 1-receptor agonists. Biochem. Biophys. Res. Commun. 201, 295-301.
118. 2 receptor stably expressed in chinese hamster ovary cells. Br. J. Pharmac. 112, 847-854.
119. Lustig K. D., Shiau A. K., Brake A. J. and Julius D. (1993) Expression cloning of an ATP receptor from mouse neuroblastoma cells. Proc. natn. Acad. Sci. USA 90, 5113-5117.
120. Marasco W. A., Phan S. H., Krutzsch H., Showell H. J., Feltner D. E., Nairn R., Becker E. L. and Ward P. A. (1984) Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 259, 5430-5439.
121. 2+ efflux. Biochem. J. 264, 357-364.
122. McLeish K. R. and Jakobs K. H. (1993) G-proteins in the signal transduction of the neutrophil. In GTPases in BiologyII, Handbook of Experimental Pharmacology. (Edited by Dickey B. F. and Birnbaumer L.), Vol. 108/II pp. 363-373. Springer, Berlin.
123. 4 and N-formylmethionyl-leucyl-phenylalanine in HL-60 cells occurs by different mechanisms. Biochem. J. 260, 427-434.
124. McLeish K. R., Gierschik P. and Jakobs K. H. (1989b) Desensitization uncouples the formyl peptide receptor-guanine nucleotide-binding protein interaction in HL60 cells. Mol. Pharmac. 36, 384-390.
125. Milligan G. (1993) Mechanisms of multifunctional signalling by G protein-linked receptors. Trends Pharmac. Sci. 14, 239-244.
126. 1 receptors during smooth muscle cell differentiation. Mol. Pharmac. 35, 311-318.
127. 2+ mobilization pathway in human HL-60 promyelocytic leukemia cells. J. Biol. Chem. 264, 18356-18362.
128. 2 receptors on human HL-60 promyelocytic leukemia cells. Mol. Pharmacol. 40, 271-275.
129. Mitsuyama T., Takeshige K. and Minakemi S. (1993) Cyclic AMP inhibits the respiratory burst of electropermeabilized human neutrophils at a downstream site of protein kinase C. Biochim. Biophys. Acta 1177, 167-173.
130. Monk P. N. and Partridge L. J. (1993) Characterization of a complement-fragment-C5a-stimulated calcium-influx mechanism in U937 monocytic cells. Biochem. J. 295, 679-684.
131. Montero M., Garcia-Sancho J. and Alvarez J. (1993) Inhibition of the calcium store-operated calcium entry pathway by chemotactic peptide and by phorbol ester develops gradually and independently along differentiation of HL60 cells. J. Biol. Chem. 268, 26911-26919.
132. 2+ entry pathway in differentiated HL60 cells. J. Biol. Chem. 269, 29451-29456.
133. 2+ entry by ATP and UTP in promyelocytic leukaemia HL60 cells. Biochem. J. 305, 879-887.
134. Mousli M., Hugli T. E., Landry Y. and Bronner C. (1994) Peptidergic pathway in human skin and rat peritoneal mast cell activation. Immunopharmacology 27, 1-11.
135. Mullmann T. J., Cheewatrakoolpong B., Anthes J. C., Siegel M. I., Egan R. W. and Billah M. M. (1993) Phospholipase C and phospholipase D are activated independently of each other in chemotactic peptide-stimulated human neutrophils. J. Leukocyte Biol. 53, 630-635.
136. Murphy P. M. (1994) The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12, 593-633.
137. Murphy P. M. and McDermott D. (1991) Functional expression of the human formyl peptide receptor in Xenopus oocytes requires a complementary human factor. J. Biol. Chem. 266, 12560-12567.
138. Murphy P. M. and Tiffany H. L. (1991) Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253, 1280-1283.
139. iα in HL60 cells. FEBS Lett. 221, 81-86.
140. Murphy P. M., Özçelik T., Kenney R. T., Tiffany H. L., McDermott D. and Francke U. (1992) A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. J. Biol. Chem. 267, 7637-7643.
141. 2-adrenoceptors. Biochem. Pharmac. 47, 233-239.
142. i-proteins in human erythroleukemia (HEL) cells: No evidence for a functional role of imidazoline receptors in modulating calcium. Biochem. Pharmac. 49, 187-196.
143. Musgrave I. F., Seifert R. and Schultz G. (1994) Maitotoxin activates cation channels distinct from the receptor-activated non-selective cation channels of HL-60 cells. Biochem. J. 301, 437-441.
144. Nonaka T., Mio M., Doi M. and Tasaka K. (1992) Histamine-induced differentiation of HL-60 cells. The role of cAMP and protein kinase A. Biochem. Pharmac. 44, 1115-1121.
145. Nüße O. and Lindau M. (1988) The dynamics of exocytosis in human neutrophils. J. Cell Biol. 107, 2117-2123.
146. O'Connor S. E. (1992) Recent developments in the classification and functional significance of receptors for ATP and UTP, evidence for nucleotide receptors. Life Sci. 50, 1657-1664.
147. Offermanns S. and Schultz G. (1994) Complex information processing by the transmembrane signaling system involving G proteins. Naunyn-Schmiedeberg's Arch. Pharmac. 350, 329-338.
148. Offermanns S., Schäfer R., Hoffmann B., Bombien E., Spicher K., Hinsch K.-D., Schultz G. and Rosenthal W. (1990) Agonist-sensitive binding of a photoreactive GTP analog to a G-protein α-subunit in membranes of HL-60 cells. FEBS Lett. 260, 14-18.
149. Oinuma M., Katada T. and Ui M. (1987) A new GTP-binding protein in differentiated human leukemic (HL-60) cells serving as the specific substrate of islet-activating protein, pertussis toxin. J. Biol. Chem. 262, 8347-8353.
150. Pang I.-H. and Sternweis P. C. (1990) Purification of unique α-subunits of GTP-binding regulatory proteins (G-proteins) by affinity chromatography with immobilized βγ-subunits. J. Biol. Chem. 48, 1857-1864.
151. 2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc. natn. Acad. Sci. USA 91, 3275-3279.
152. Perez H. D., Kelly E. and Holmes R. (1992) Regulation of formyl peptide receptor expression and its mRNA levels during differentiation of HL-60 cells. J. Biol. Chem. 267, 358-363.
153. Perry D. K., Stevens V. L., Widlanski T. S. and Lambeth J. D. (1993) A novel ecto-phosphatidic acid phosphohydrolase activity mediates activation of neutrophil superoxide generation by phosphatidic acid. J. Biol. Chem. 268, 25302-25310.
154. 2+ influx across the plasma membrane of HL-60 cells. A role for cytosolic free calcium elevations and inositol 1,3,4,5-tetrakisphosphate production. J. Biol. Chem. 264, 7251-7261.
155. Prossnitz E. R., Quehenberger O., Cochrane C. G. and Ye R. D. (1993a) The role of the third intracellular loop of the neutrophil N-formyl peptide receptor in G protein coupling. Biochem. J. 294, 581-587.
156. Prossnitz E. R., Quehenberger O., Cochrane C. G. and Ye R. D. (1993b) Signal transducing properties of the N-formyl peptide receptor expressed in undifferentiated HL60 cells. J. Immunol. 151, 5704-5715.
157. Prossnitz E. R., Kim C. M., Benovic J. L. and Ye R. D. (1995) Phosphorylation of the N-formyl peptide receptor carboxyl terminus by the G protein-coupled receptor kinase, GRK2. J. Biol. Chem. 270, 1130-1137.
158. Qui R., Melmon K. L. and Khan M. M. (1990) Effects of histamine-trifluoromethyl-toluidide derivative (HTMT) on intracellular calcium in human lymphocytes. J. Pharmac. Exp. Ther. 253, 1245-1252.
159. Qui R., Melmon K. L. and Khan M. M. (1993) A histamine derivative increases intracellular calcium mobilization and oxidative metabolism in HL-60 cells. Immunopharmacology 26, 213-224.
160. 1-receptor antagonists: comparative pharmacology and clinical use. Klin. Wochenschr. 60, 983-990.
161. 2-forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function. Biochim. Biophys. Acta 853, 65-89.
162. 2-receptor gene. Biochem. Biophys. Res. Commun. 179, 1470-1478.
163. Sager G., Bang B. E., Pedersen M. and Aarbakke J. (1988) The human promyelocytic leukemia cell (HL-60 cell) β-adrenergic receptor. J. Leukocyte Biol. 44, 41-45.
164. Saiag B., Milon D., Shacoori V., Allain H., Rault B., van den Drissche J. (1992) Newly evidenced pyrimidinoceptors and the P2X purinoceptors are present on the vascular smooth muscle and respectively mediate the UTP- and ATP-induced contractions of the dog maxillary internal vein. Res. Commun. Chem. Pathol. Pharmac. 76, 89-94.
165. 2 receptor desensitization in HL-60 human promyelocytic leukemia cells. J. Pharmac. Exp. Ther. 231, 1-7.
166. 4 receptors. Biochem. J. 289, 469-473.
167. 4 receptors. J. Biol. Chem. 267, 159-165.
168. Schreiber R. E., Prossnitz E. R., Ye R. D., Cochrane C. G., Jesaitis A. J. and Bokoch G. M. (1993) Reconstitution of recombinant N-formyl chemotactic peptide receptor with G protein. J. Leukocyte Biol. 53, 470-474.
169. Schütz W. and Freissmuth M. (1992) Reverse intrinsic activity of antagonists on G protein-coupled receptors. Trends Pharmac. Sci. 13, 376-380.
170. 2-receptor antagonists? Aliment. Pharmac. Therap. 1, 493S-503S.
171. Schultz P., Stannek P., Voigt M., Jakobs K. H. and Gierschik P. (1992) Complementation of formyl peptide receptor-mediated signal transduction in Xenopus laevis oocytes. Biochem. J. 284, 207-212.
172. 2+ in the human erythroleukemia cell line involve pertussis toxin-sensitive and -insensitive pathways. Biochem. J. 281, 301-307.
173. Seibenhenner M. L. and Wooten M. W. (1993) Heterogeneity of protein kinase C isoform expression in chemically induced HL60 cells. Exp. Cell. Res. 207, 183-188.
174. Seifert R. and Schultz G. (1989) Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides. Trends Pharmac. Sci. 10, 365-369.
175. Seifert R. and Schultz G. (1991) The superoxide-forming NADPH oxidase of phagocytes: an enzyme system regulated by multiple mechanisms. Rev. Physiol. Biochem. Pharmac. 117, 1-338.
176. Seifert R., Rosenthal W. and Schultz G. (1986) Guanine nucleotides stimulate NADPH oxidase in membranes of human neutrophils. FEBS Lett. 205, 161-165.
177. Seifert R., Rosenthal W., Schultz G., Wieland T., Gierschik P. and Jakobs K. H. (1988) The role of nucleoside-diphosphate kinase reactions in G protein activation of NADPH oxidase by guanine and adenine nucleotides. Eur. J. Biochem. 175, 51-55.
178. Seifert R., Burde R. and Schultz G. (1989a) Activation of NADPH oxidase by purine and pyrimidine nucleotides involves G proteins and is potentiated by chemotactic peptides. Biochem. J. 259, 813-819.
179. Seifert R., Burde R. and Schultz G. (1989b) Lack of effect of opioid peptides, morphine and naloxone on superoxide formation in human neutrophils and HL-60 leukemic cells. Naunyn-Schmiedeberg's Arch. Pharmac. 340, 101-106.
180. Seifert R., Wenzel K., Eckstein K. and Schultz G. (1989c) Purine and pyrimidine nucleotides potentiate activation of NADPH oxidase and degranulation by chemotactic peptides and induce aggregation of human neutrophils via G-proteins. Eur. J. Biochem. 181, 277-285.
181. Seifert R., Jungblut P. and Schultz G. (1989d) Differential expression of cytosolic activation factors for NADPH oxidase in HL-60 leukemic cells. Biochem. Biophys. Res. Commun. 161, 1109-1117.
182. Seifert R., Hilgenstock G., Fassbender M. and Distler A. (1990) Regulation of the superoxide-forming NADPH oxidase of human neutrophils is not altered in essential hypertension. J. Hypertension 9, 147-153.
183. Seifert R., Serke S., Huhn D., Bessler W. G., Hauschildt S., Metzger J., Wiesmüller K.-H. and Jung G. (1992a) Incomplete functional differentiation of HL-60 leukemic cells by synthetic lipopeptides. Partial inhibition by pertussis toxin of enhanced superoxide formation. Eur. J. Biochem. 203, 143-151.
184. 2+ in dibutyryl-cAMP-differentiated HL-60 cells via HI receptors and is an incomplete secretagogue. Mol. Pharmac. 42, 227-234.
185. 2 receptors with an unique agonist/antagonist profile and induces functional differentiation. Mol. Pharmac. 42, 235-241.
186. i proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes. Mol. Pharmac. 45, 578-586.
187. 2+ mobilization. Naunyn-Schmiedeberg's Arch. Pharmac. 349, 355-361.
188. Seligmann B. E., Fletcher M. P. and Gallin J. I. (1983) Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes. J. Immunol. 130, 1902-1909.
189. Sirak A. A., Laskin J. D., Robertson F. M. and Laskin D. L. (1990) Failure of F-Met-Leu-Phe to induce chemotaxis in differentiated promyelocytic (HL-60) leukemia cells. J. Leukocyte Biol. 48, 333-342.
190. Smith C. D., Uhing R. J. and Snyderman R. (1987) Nucleotide regulatory protein-mediated activation of phospholipase C in human polymorphonuclear leukocytes is disrupted by phorbol esters. J. Biol. Chem. 262, 6121-6127.
191. Smolen J. E., Stoehr S. J., Kuczynski B., Koh E. K. and Omann G. M. (1991) Dual effects of guanosine 5′-[γ-thio]triphosphate by electroporated human neutrophils. Biochem. J. 279, 657-664.
192. Stasek J. E. Jr., Natarajan V. and Garcia J. G. N. (1993) Phosphatidic acid activates endothelial cell protein kinase C. Biochem. Biophys. Res. Commun. 191, 134-141.
193. Sternweis P. C. and Smrcka A. V. (1992) Regulation of phospholipase C by G proteins. Trends Biochem. Sci. 17, 502-506.
194. Strader C. D., Ming Fong T., Tota M. R. and Underwood D. (1994) Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63, 101-132.
195. Strathmann M. P. and Simon M. I. (1991) Ga12 and Ga13 subunits define a fourth class of G protein a subunits. Proc. natn. Acad. Sci. USA 88, 5582-5586.
196. Stutchfield J. and Cockcroft S. (1990) Undifferentiated HL60 cells respond to extracellular ATP and UTP by stimulating phospholipase C activation and exocytosis. FEBS Lett. 262, 256-258.
197. Stutchfield J. and Cockcroft S. (1993) Correlation between secretion and phospholipase D activation in differentiated HL60 cells. Biochem. J. 293, 649-655.
198. Sullivan R., Griffin J. D. and Malech H. L. (1987) Acquisition of formyl peptide receptors during normal human myeloid differentiation. Blood 70, 1222-1224.
199. 2 purinoceptor-mediated cyclic AMP accumulation in bovine vascular smooth muscle cells. Eur. J. Biochem. 227, 25-31.
200. Tardif M., Mery L., Brouchon L. and Boulay F. (1993) Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells. J. Immunol. 150, 3534-3545.
201. Tasaka K. (1991) Histamine and the blood. In Handbook of Experimental Pharmacology. Vol. 97. Histamine and Histamine Antagonists (Edited by Uvnäs, B.), pp. 473-510. Springer, Berlin.
202. Thelen M. and Baggiolini M. (1990) Reconstitution of cell-free N ADPH-oxidase from human monocytes and comparison with neutrophils. Blood 75, 2223-2228.
203. Thomas G., Chomienne C., Balitrand N., Schaison G., Abita J.-P. and Baulieu E. E. (1986) Granulocytic differentiation induced by retinoic acid in HL-60 cells is associated with changes in adenylate cyclase activity. Anticancer Res. 6, 857-860.
204. Thompson B. Y., Sivam G., Britigan B. E., Rosen G. M. and Cohen M. S. (1988) Oxygen metabolism of the HL-60 cell line: Comparison of the effects of monocytoid and neutrophilic differentiation. J. Leukocyte Biol. 43, 140-147.
205. 1 receptors. J. Cell Biol. 110, 1211-1215.
206. Tohkin M., Morishima N., Iiri T., Takahashi K., Ui M. and Katada T. (1991) Interaction of guanine-nucleotide-binding regulatory proteins with chemotactic peptide receptors in differentiated human leukemic HL-60 cells. Eur. J. Biochem. 195, 527-533.
207. Tomhave E. D., Richardson R. M., Didsbury J. R., Menard L., Snyderman R. and Ali H. (1994) Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation. J. Immunol. 153, 3267-3275.
208. 2 receptor mediating inhibition of arachidonate release and activation of cAMP accumulation. Proc. natn. Acad. Sci. USA 89, 2649-2653.
209. Uhing R. J., Polakis P. G. and Snyderman R. (1987) Isolation of GTP-binding protein from myeloid HL-60 cells. Identification of two pertussis toxin substrates. J. Biol. Chem. 262, 15575-15579.
210. Vallari D. S., Austinhirst R. and Snyder F. (1990) Development of specific functionally active receptors for platelet-activating factor in HL-60 cells following granulocytic differentiation. J. Biol. Chem. 265, 4261-4265.
211. 2 antagonists. In Handbook of Experimental Pharmacology. Vol. 97. Histamine and Histamine antagonists (Edited by Uvnäs B.), pp. 573-748. Springer, Berlin.
212. 1 MF-2 cells. Biochem. J. 305, 859-864.
213. van Riper G., Nicholson D. W., Scheid M. P., Fischer P. A., Springer M. S. and Rosen H. (1994) Induction, characterization, and functional coupling of the high affinity chemokine receptor for RANTES and macrophage inflammatory protein-1α upon differentiation of an eosinophilic HL-60 cell line. J. Immunol. 152, 4055-4061.
214. 2X-receptor, in rabbit basilar artery: a receptor for pyrimidine nucleotides and a receptor for purine nucleotides. Naunyn-Schmiedeberg's Arch. Pharmac. 341, 538-546.
215. Warlow R. S., Rajasekariah P., Lambert P., Morgan J., Phuong Dao L., Bernard C. C. A. and Walls R. S. (1994) Purification of histamine receptor proteins from detergent-solubilized human peripheral blood mononuclear cells. Biochemistry 33, 4800-4811.
216. Warrell R. Jr., de Thé H., Wang Z.-Y. and Degos L. (1993) Acute promyelocytic leukemia. New Engl. J. Med. 329, 177-189.
217. Webb T. E., Simon J., Krishek B. J., Bateson A. N., Smart T. G., King B. F., Burnstock G. and Barnard E. A. (1993) Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett. 324, 219-225.
218. Weiss S. J. (1989) Tissue destruction by neutrophils. New Engl. J. Med. 320, 365-376.
219. Wenzel-Seifert K. and Seifert R. (1990) Nucleotide-, chemotactic peptide- and phorbol ester-induced exocytosis in HL-60 leukemic cells. Immunobiology 181, 298-316.
220. Wenzel-Seifert K. and Seifert R. (1993) Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L- phenylalanine and cyclosporins A, B, C, D and E. J. Immunol. 150, 4591-4599.
221. Wenzel-Seifert K., Grünbaum L. and Seifert R. (1991a) Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation. J. Immunol. 147, 1940-1946.
222. Wenzel-Seifert K., Ervens J. and Seifert R. (1991b) Differential inhibition and potentiation by cell-permeant analogues of cyclic AMP and cyclic GMP and NO-containing compounds of exocytosis in human neutrophils. Naunyn-Schmiedeberg's Arch. Pharmac. 344, 396-402.
223. Wenzel-Seifert K., Schächtele C. and Seifert R. (1994) N-protein kinase C isoenzymes may be involved in the regulation of various neutrophil functions. Biochem. Biophys. Res. Commun. 200, 1536-1543.
224. 2+ and the regulation of early response gene expression in HL-60 myeloid leukemia cells. J. Biol. Chem. 268, 16596-16601.
225. Wescott S. and Kaliner M. (1983) Histamine H-1 binding site on human polymorphonuclear leukocytes. Inflammation 7, 291-300.
226. Wheeldon A. and Vardey J. J. (1993) Characterization of the inhibitory prostanoid receptors on human neutrophils. Br. J. Pharmac. 108, 1051-1054
227. 1MF-2 cells: agonist and antagonist properties. Br. J. Pharmac. 108, 196-203.
228. Wieland T. and Jakobs K. H. (1992) Evidence for nucleoside diphosphokinase-dependent channeling of guanosine 5′-(γ-thio)triphosphate to guanine nucleotide-binding proteins. Mol. Pharmac. 42, 731-735.
229. Wieland T., Kreiss J., Gierschik P. and Jakobs K. H. (1992a) Role of GDP in formyl-peptide-receptor-induced activation of guanine-nucleotide-binding proteins in membranes of HL 60 cells. Eur. J. Biochem. 205, 1201-1206.
230. Wieland T., Gierschik P. and Jakobs K. H. (1992b) G protein-mediated receptor-receptor interaction: studies with chemotactic receptors in membranes of human leukemia (HL 60) cells. Naunyn-Schmiedeberg's Arch. Pharmac. 346, 475-481.
231. Wieland T., Nürnberg B., Ulibarri I., Kaldenberg-Stasch S., Schultz G. and Jakobs K. H. (1993) Guanine nucleotide-specific phosphate transfer by guanine nucleotide-binding regulatory protein β-subunits. Characterization of the phosphorylated amino acid. J. Biol. Chem. 268, 18111-18118.
232. 2 formation reveal a rapid agonist-induced transduction process. J. Biol. Chem. 262, 12048-12053.
233. 2-purinergic- and chemotactic peptide-receptor agonists is induced during granulocytic differentiation of HL-60 cells. J. Clin. Invest. 88, 45-54.
234. 2U purinergic receptors in dibutyryl cyclic AMP-differentiated HL60 cells. J. Biol. Chem. 267, 6602-6610.
235. Yamashita M., Fukui H., Sugama K., Horio Y., Ito S., Mizuguchi H. and Wada H. (1991) Expression cloning of a cDNA encoding the bovine histamine Hi receptor. Proc. natn. Acad. Sci. USA 88, 11515-11519.
236. Yu G. H., Trapchak S. J., Walker B. A. M. and Ward P. A. (1991) Adenosine-5′-O-(3-thiotriphosphate) binding to human neutrophils. Evidence for a common nucleotide receptor. Lab. Invest. 65, 316-323.
237. 1-agonistic activity. Eur. J. Med. Chem. 25, 673-680.